Golden Biotechnology Corporation (TPEX:4132)
Taiwan · Delayed Price · Currency is TWD 10.85
-0.55 (-4.82%)
Aug 1, 2025, 1:38 PM CST
Verve Therapeutics Revenue
In the year 2024, Golden Biotechnology had annual revenue of 40.92M TWD, down -35.49%. Golden Biotechnology had revenue of 17.97M in the half year ending December 31, 2024, a decrease of -88.55%.
Revenue
40.92M
Revenue Growth
-35.49%
P/S Ratio
45.20
Revenue / Employee
335.39K
Employees
122
Market Cap
1.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40.92M | -22.51M | -35.49% |
| Dec 31, 2023 | 63.43M | -154.40M | -70.88% |
| Dec 31, 2022 | 217.83M | 136.06M | 166.39% |
| Dec 31, 2021 | 81.77M | -7.06M | -7.94% |
| Dec 31, 2020 | 88.83M | 5.53M | 6.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 117.33M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Pegavision | 6.67B |